BNP Paribas Financial Markets’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-29,789
| Closed | -$85.8K | – | 3681 |
|
2021
Q4 | $85.8K | Buy |
+29,789
| New | +$85.8K | ﹤0.01% | 3001 |
|
2021
Q3 | – | Sell |
-16
| Closed | -$85 | – | 3449 |
|
2021
Q2 | $85 | Hold |
16
| – | – | ﹤0.01% | 3410 |
|
2021
Q1 | $74 | Hold |
16
| – | – | ﹤0.01% | 3384 |
|
2020
Q4 | $53 | Hold |
16
| – | – | ﹤0.01% | 3423 |
|
2020
Q3 | $53 | Sell |
16
-51,586
| -100% | -$171K | ﹤0.01% | 3508 |
|
2020
Q2 | $174K | Buy |
51,602
+44,507
| +627% | +$150K | ﹤0.01% | 1947 |
|
2020
Q1 | $27.2K | Buy |
7,095
+3,793
| +115% | +$14.5K | ﹤0.01% | 3202 |
|
2019
Q4 | $19.9K | Buy |
3,302
+655
| +25% | +$3.96K | ﹤0.01% | 3340 |
|
2019
Q3 | $20K | Buy |
2,647
+2,588
| +4,386% | +$19.6K | ﹤0.01% | 3307 |
|
2019
Q2 | $799 | Sell |
59
-206
| -78% | -$2.79K | ﹤0.01% | 3751 |
|
2019
Q1 | $1.44K | Hold |
265
| – | – | ﹤0.01% | 3539 |
|
2018
Q4 | $787 | Sell |
265
-6
| -2% | -$18 | ﹤0.01% | 3274 |
|
2018
Q3 | $2.21K | Hold |
271
| – | – | ﹤0.01% | 3573 |
|
2018
Q2 | $2.64K | Sell |
271
-2,299
| -89% | -$22.4K | ﹤0.01% | 3570 |
|
2018
Q1 | $22.3K | Buy |
2,570
+50
| +2% | +$434 | ﹤0.01% | 3316 |
|
2017
Q4 | $31.6K | Buy |
2,520
+1,407
| +126% | +$17.6K | ﹤0.01% | 3188 |
|
2017
Q3 | $9.31K | Sell |
1,113
-82
| -7% | -$686 | ﹤0.01% | 3330 |
|
2017
Q2 | $20.3K | Buy |
1,195
+1,194
| +119,400% | +$20.3K | ﹤0.01% | 3115 |
|
2017
Q1 | $20 | Hold |
1
| – | – | ﹤0.01% | 3447 |
|
2016
Q4 | $16 | Hold |
1
| – | – | ﹤0.01% | 3436 |
|
2016
Q3 | $13 | Hold |
1
| – | – | ﹤0.01% | 3526 |
|
2016
Q2 | $7 | Sell |
1
-56
| -98% | -$392 | ﹤0.01% | 3550 |
|
2016
Q1 | $539 | Sell |
57
-583
| -91% | -$5.51K | ﹤0.01% | 2553 |
|
2015
Q4 | $6.44K | Hold |
640
| – | – | ﹤0.01% | 3440 |
|
2015
Q3 | $9.16K | Buy |
+640
| New | +$9.16K | ﹤0.01% | 3435 |
|